LUNIT INC
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology 2024-01-17 22:15
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening 2024-01-16 22:04
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed 2023-12-14 22:05
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project 2023-12-11 22:30
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging 2023-11-30 22:10
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology 2023-11-27 22:05
Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology 2023-11-22 22:07
Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals 2023-11-16 22:00
Lunit Secures $150 Million in Capital Increase 2023-11-15 22:00
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT 2023-11-14 22:00
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care 2023-11-13 22:00
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023 2023-11-06 21:00
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023 2023-11-01 21:08
Lunit Joins as an Associate Partner with the World Economic Forum 2023-10-31 21:00
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy 2023-10-27 21:07
Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation 2023-10-26 21:00
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO 2023-10-24 21:00
New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023 2023-10-16 21:10
Lunit to Showcase 9 AI-based Research Results at ESMO 2023 2023-10-10 21:00
Lunit to Reveal 6 Abstracts at the SITC 2023 Annual Meeting 2023-09-27 22:03
1 2 3 4 5 6